-
Je něco špatně v tomto záznamu ?
Homocysteine and Real-Space Navigation Performance among Non-Demented Older Adults
M. Pařízková, R. Andel, O. Lerch, H. Marková, I. Gažová, M. Vyhnálek, J. Hort, J. Laczó,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
PubMed
27802238
DOI
10.3233/jad-160667
Knihovny.cz E-zdroje
- MeSH
- bludiště - učení fyziologie MeSH
- diskriminace (psychologie) MeSH
- homocystein krev MeSH
- kognitivní dysfunkce krev patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- neuropsychologické testy MeSH
- prostorová navigace fyziologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- sluchová percepce fyziologie MeSH
- stárnutí krev fyziologie MeSH
- studie případů a kontrol MeSH
- záznam o duševním stavu MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: High plasma homocysteine (Hcy) level is related to higher risk of Alzheimer's disease (AD) and lower cognitive performance in older adults. OBJECTIVE: To assess the association between plasma Hcy level and real-space navigation performance and the role of vascular risk and protective factors, APOE status, and white matter lesions (WML) on this association. METHODS: Ninety-two non-demented older adults (29 with amnestic mild cognitive impairment, 46 with subjective cognitive decline, and 17 cognitively normal older adults) underwent spatial navigation testing of egocentric, allocentric, and mixed navigation in a real-space analogue of the Morris water maze, neuropsychological examination, blood collection, and MRI brain scan with evaluation of WML. RESULTS: In the regression analyses controlling for age, gender, education, and depressive symptoms, higher plasma Hcy level was related to worse mixed and egocentric (β= 0.31; p = 0.003 and β= 0.23; p = 0.017) but not allocentric (p > 0.05) navigation performance. Additional controlling for vascular risk and protective factors, WML, and APOE status did not modify the results. High total cholesterol and low vitamin B12 and folate levels increased the adverse effect of Hcy on egocentric and mixed navigation. WML did not explain the association between plasma Hcy level and navigation performance. CONCLUSION: Elevated plasma Hcy level may affect real-space navigation performance above and beyond vascular brain changes. This association may be magnified in the presence of high total cholesterol and low folate or vitamin B12 levels. Attention to the level of plasma Hcy may be a viable intervention strategy to prevent decline in spatial navigation in non-demented older adults.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010960
- 003
- CZ-PrNML
- 005
- 20180404142432.0
- 007
- ta
- 008
- 180404s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3233/JAD-160667 $2 doi
- 035 __
- $a (PubMed)27802238
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pařízková, Martina $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
- 245 10
- $a Homocysteine and Real-Space Navigation Performance among Non-Demented Older Adults / $c M. Pařízková, R. Andel, O. Lerch, H. Marková, I. Gažová, M. Vyhnálek, J. Hort, J. Laczó,
- 520 9_
- $a BACKGROUND: High plasma homocysteine (Hcy) level is related to higher risk of Alzheimer's disease (AD) and lower cognitive performance in older adults. OBJECTIVE: To assess the association between plasma Hcy level and real-space navigation performance and the role of vascular risk and protective factors, APOE status, and white matter lesions (WML) on this association. METHODS: Ninety-two non-demented older adults (29 with amnestic mild cognitive impairment, 46 with subjective cognitive decline, and 17 cognitively normal older adults) underwent spatial navigation testing of egocentric, allocentric, and mixed navigation in a real-space analogue of the Morris water maze, neuropsychological examination, blood collection, and MRI brain scan with evaluation of WML. RESULTS: In the regression analyses controlling for age, gender, education, and depressive symptoms, higher plasma Hcy level was related to worse mixed and egocentric (β= 0.31; p = 0.003 and β= 0.23; p = 0.017) but not allocentric (p > 0.05) navigation performance. Additional controlling for vascular risk and protective factors, WML, and APOE status did not modify the results. High total cholesterol and low vitamin B12 and folate levels increased the adverse effect of Hcy on egocentric and mixed navigation. WML did not explain the association between plasma Hcy level and navigation performance. CONCLUSION: Elevated plasma Hcy level may affect real-space navigation performance above and beyond vascular brain changes. This association may be magnified in the presence of high total cholesterol and low folate or vitamin B12 levels. Attention to the level of plasma Hcy may be a viable intervention strategy to prevent decline in spatial navigation in non-demented older adults.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a stárnutí $x krev $x fyziologie $7 D000375
- 650 _2
- $a sluchová percepce $x fyziologie $7 D001307
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a kognitivní dysfunkce $x krev $x patofyziologie $7 D060825
- 650 _2
- $a diskriminace (psychologie) $7 D004192
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a homocystein $x krev $7 D006710
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a bludiště - učení $x fyziologie $7 D018782
- 650 _2
- $a záznam o duševním stavu $7 D008609
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a prostorová navigace $x fyziologie $7 D065854
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Andel, Ross $u School of Aging Studies, University of South Florida, Tampa, FL, USA. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Lerch, Ondřej $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Marková, Hana $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Gažová, Ivana $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Vyhnálek, Martin $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Hort, Jakub $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Laczó, Jan $u Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 773 0_
- $w MED00006350 $t Journal of Alzheimer's disease JAD $x 1875-8908 $g Roč. 55, č. 3 (2017), s. 951-964
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27802238 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142512 $b ABA008
- 999 __
- $a ok $b bmc $g 1288445 $s 1007772
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 55 $c 3 $d 951-964 $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
- LZP __
- $a Pubmed-20180404